NCT00718055

Brief Summary

The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2006

Completed
28 days until next milestone

Study Start

First participant enrolled

November 1, 2006

Completed
1.7 years until next milestone

First Posted

Study publicly available on registry

July 18, 2008

Completed
Last Updated

February 10, 2009

Status Verified

February 1, 2009

First QC Date

October 4, 2006

Last Update Submit

February 9, 2009

Conditions

Neoplasm MetastasisLiverColorectal NeoplasmsMagnetic Resonance ImagingContrast Media

Keywords

MRIliverspecificcontrastcolorectalmetastases

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

consekutive group of liver metastatic patients

You may qualify if:

  • biopsy proved liver metastasis

You may not qualify if:

  • pacemaker, metal in the body, claustrophobia, pregnancy, age below 18 years, psychiatry patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Copenhagen Uni. Hospital at Herlev dept. of Radiology

Herlev, 2730, Denmark

Location

MeSH Terms

Conditions

Neoplasm MetastasisColorectal Neoplasms

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and SymptomsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Vibeke Løgager, M.D.

    Copenhagen University Hospital at Herlev

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 4, 2006

First Posted

July 18, 2008

Study Start

November 1, 2006

Last Updated

February 10, 2009

Record last verified: 2009-02

Locations

DK(1)